Ana M. Gajate-Samanes

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Serial amyloid PET as a decision tool for switching anti-amyloid therapy in Alzheimer's disease.

Serial amyloid PET as a decision tool for switching anti-amyloid therapy in Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 09, 2026

From Target Engagement to Treatment Governance: The Evolving Role of Amyloid PET in Anti-Amyloid Therapy.

From Target Engagement to Treatment Governance: The Evolving Role of Amyloid PET in Anti-Amyloid Therapy.

Journal: The Lancet regional health. Europe

Published: February 25, 2026

Real-world implementation of lecanemab and donanemab in an Italian memory center: a 1-year experience.

Real-world implementation of lecanemab and donanemab in an Italian memory center: a 1-year experience.

Journal: Alzheimer's research & therapy

Published: January 07, 2026

[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment.

[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment.

Journal: Cancers

Published: December 09, 2025

Primary melanoma of the gastrointestinal tract.

Primary melanoma of the gastrointestinal tract.

Journal: World journal of gastroenterology

Published: September 25, 2025

Diagnostic Accuracy of Fully Hybrid PET/MRI with [68Ga]Ga-PSMA-11 and [68Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard.

Diagnostic Accuracy of Fully Hybrid PET/MRI with [68Ga]Ga-PSMA-11 and [68Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 25, 2025

The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference.

The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference.

Journal: Cancers

Published: October 31, 2024

Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.

Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 10, 2024

Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment.

Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment.

Journal: Magnetic resonance imaging clinics of North America

Published: September 23, 2023

Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy.

Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy.

Journal: Cancers

Published: August 04, 2023

[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration.

[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration.

Journal: Bioengineering (Basel, Switzerland)

Published: July 24, 2023

Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial.

Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 15, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026